BI-891065

N/A

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameBI-891065
Drug Alias NameBI-891065
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsCellular inhibitor of apoptosis protein 1 inhibitorsDiablo homolog, mitochondrial stimulants
TargetsCellular inhibitor of apoptosis protein 1Diablo homolog, mitochondrial
Therapy Area/IndicationsNeoplasm MetastasisCarcinoma, Non-Small-Cell LungNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsNeoplasm MetastasisCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A